Myriad Genetics, Inc. (MYD.F)
Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests.
2.92-0.33%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago-11.6%
The outlook
Myriad Genetics, Inc. currently reads as bearish based on below its 50- & 200-day averages, 0% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$275.6M
52-wk high
7.10
52-wk low
2.92
50-day avg
4.38
200-day avg
4.69
Trailing P/E
—